Mark May
About Mark May
Mark May serves as the Director of Accounting at Sonoma Biotherapeutics in the San Francisco Bay Area, a position he has held since 2021. He has extensive experience in accounting, having previously worked at Deloitte & Touche LLP, Medivation, and Sangamo Therapeutics.
Work at Sonoma BioTherapeutics
Mark May has served as the Director of Accounting at Sonoma BioTherapeutics since 2021. In this role, he is responsible for overseeing the accounting operations within the organization. His tenure at Sonoma BioTherapeutics has lasted for three years, during which he has contributed to the financial management and reporting processes of the company, located in the San Francisco Bay Area.
Previous Experience in Accounting
Prior to his current position, Mark May worked at several notable organizations. He began his career at Deloitte & Touche LLP, where he served as an Accountant from 2010 to 2013. Following this, he held the role of Accounting Manager at Medivation from 2013 to 2017. He then transitioned to Sangamo Therapeutics, Inc., where he worked as Associate Director of Accounting from 2017 until 2021, further developing his expertise in the field.
Education and Expertise
Mark May earned his Bachelor of Arts degree in Accounting from Santa Clara University Leavey School of Business, completing his studies from 2006 to 2010. His educational background has provided him with a solid foundation in accounting principles and practices, which he has applied throughout his professional career.
Career Progression in Accounting
Mark May's career in accounting reflects a steady progression through various roles and responsibilities. After starting as an Accountant at Deloitte & Touche LLP, he advanced to an Accounting Manager position at Medivation. His experience continued to grow as he took on the role of Associate Director of Accounting at Sangamo Therapeutics, before assuming his current position at Sonoma BioTherapeutics.